News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
The biotech giant that soared during Operation Warp Speed now faces regulatory hurdles, political scepticism, and dwindling ...
Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...
Stocktwits on MSN5d
Moderna Stock Drops On HHS Funding Termination For Pandemic Flu Vaccine; Retail Turns BearishShares of Moderna Inc. fell over 2% on Wednesday after the U.S. Department of Health and Human Services (HHS) withdrew its ...
The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.
The Trump administration’s decision to yank nearly $600 million in promised bird flu vaccine funding is the latest worrying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback